Shopping Cart
- Remove All
- Your shopping cart is currently empty
TrxR-IN-5 (compound 4f) is an efficacious inhibitor of TrxR (thioredoxin reductase) with an IC50 of 0.16 μM. By elevating the levels of reactive oxygen species (ROS), TrxR-IN-5 fosters robust antiproliferative impacts and demonstrates pronounced effects against cancer proliferation and metastasis [1].
Pack Size | Price | Availability | Quantity |
---|---|---|---|
2 mg | $59 | 5 days |
Description | TrxR-IN-5 (compound 4f) is an efficacious inhibitor of TrxR (thioredoxin reductase) with an IC50 of 0.16 μM. By elevating the levels of reactive oxygen species (ROS), TrxR-IN-5 fosters robust antiproliferative impacts and demonstrates pronounced effects against cancer proliferation and metastasis [1]. |
In vivo | TrxR-IN-5 (compound 4f), administered intraperitoneally (IP) at doses ranging from 0 to 25 mg/kg once to BALB/c nude mice with MDA-MB-231 xenografts, demonstrates significant inhibitory effects on solid breast cancer tumors in vivo [1]. |
Molecular Weight | 382.45 |
Formula | C26H22O3 |
Storage | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.